Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Novartis_AG
|
| gptkbp:acquired |
gptkb:Novartis
|
| gptkbp:acquisition |
Acquired by Novartis
|
| gptkbp:clinical_trial |
Conducted multiple clinical trials for its products
|
| gptkbp:focus |
Dermatology
|
| gptkbp:founded |
gptkb:2014
gptkb:2016 |
| gptkbp:founder |
gptkb:Dr._David_A._H._H._Ziarco
|
| gptkbp:headquarters |
gptkb:United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ziarco Pharma
|
| gptkbp:partnership |
Collaborated with various research institutions
|
| gptkbp:products |
Topical treatments
Ziarco's lead product |
| gptkbp:research |
Innovative treatments for skin diseases
|
| gptkbp:research_areas |
Inflammatory skin diseases
|
| gptkbp:type |
gptkb:Company
|
| gptkbp:website |
www.ziarcopharma.com
|